The BCS group synthesizes and characterizes nanoparticles and nanocolloidal systems
designed for efficient delivery of bioactive components (i.e. vitamins, antioxidants,
antifungals, etc.). Controlled-release, safety and bioavailability studies are performed
to insure that application-specific (i.e. food, cosmetic or pharmaceutical) criteria
for the designed delivery system are met.
Cristina Sabliov, Ph. D.
Carlos Astete, Ph.D.